---
schema_version: "secwatch.filing_event.v1"
accession: "0000886163-21-000102"
form_type: "8-K"
ticker: "LGND"
cik: "0000886163"
company_name: "LIGAND PHARMACEUTICALS INC"
filed_at: "2021-07-14T23:59:59+00:00"
generated_at: "2026-06-30T05:35:09.454638+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Ligand appoints Dr. Jennifer Cochran to board; moves headquarters to Emeryville, CA

## Summary
- Dr. Jennifer Cochran appointed to board effective July 12, 2021; co-founder of xCella acquired by Ligand in Dec 2020.
- Cochran receives RSUs (1,161 shares) and options (4,508 shares at $126.36) vesting over 3 years plus cash comp.
- Corporate headquarters moved to 5980 Horton Street, Suite 405, Emeryville, CA 94608 effective July 14, 2021; phone unchanged.
- Cochran is Shriram Chair of Bioengineering at Stanford, co-founded Red Tree Venture Capital, and serves on multiple biotech boards.

## SEC filing metadata
- accession: 0000886163-21-000102
- form_type: 8-K
- ticker: LGND
- cik: 0000886163
- company_name: LIGAND PHARMACEUTICALS INC
- filed_at: 2021-07-14T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/886163/000088616321000102/0000886163-21-000102-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/886163/000088616321000102/lgnd-20210712.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000886163-21-000102
- JSON: https://secwatch.observer/filing/0000886163-21-000102.json
- Plain text: https://secwatch.observer/filing/0000886163-21-000102.txt

## Key facts
- Executive change
  Jennifer Cochran was appointed as Director at LIGAND PHARMACEUTICALS INC.
  - Action: appointed
  - Role: Director
  source text: Effective as of July 12, 2021, the Board of Directors of Ligand Pharmaceuticals Incorporated (the “Company”) appointed Jennifer Cochran, Ph.D., to the Company’s Board of Directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/886163/000088616321000102/0000886163-21-000102-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.